open access: 2012 Pharmaceutical care for patients with breast and ovarian cancer

open access

Purpose
Individualized patient care may help reduce the
incidence of adverse drug events in systemic cancer therapy.
This study was conducted to explore the feasibility and
potential of additional pharmaceutical care for breast and
ovarian cancer patients.

Conclusions
In conclusion, our results suggest that pharmaceutical care for
patients with breast and ovarian cancer is feasible and may
have an impact on PROs as particularly indicated by significant
improvements of the antiemetic response and patient
satisfaction. Although there is no doubt that a higher awareness
of drug-related problems is beneficial, final conclusions
on the effectiveness of a new health care intervention can only
be drawn when studied in a randomized trial. Therefore,
our data may serve as a valuable basis for planning a
large randomized multicenter trial.